Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2016-10-24
Product name
SOLIQUA 100/33TM
Substance name
Mixture of lixisenatide and insulin glargine (rDNA origin)
1.2.1 Relevant identified uses
Pharmaceutical product
supplier name
Sanofi-aventis U.S. LLC A SANOFI Company
Icons in SDS
Company Information
company name
Sanofi-aventis U.S. LLC A SANOFI Company
Section 2
2.1 Classification of the substance or mixture
Toxic to reproduction, Category 2 2.2 Label elements in accordance with 29 CFR 1910.1200 Labeling of the finished drug product is not required according to OSHA 29 CFR 1910.1200. The following information is provided for the drug product mixture:
Hazard statements
Suspected of damaging the unborn child
Hazard pictograms
Health hazard
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear eye protection, protective gloves and protective clothing.
Response
If exposed or concerned Get medical advice
Storage
Store locked up
Disposal
Dispose of contents in accordance with local and national regulations
2.3 Other hazards
Not classified.
